Guidance Document: Part C, Division 5 of the Food and Drug Regulations “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100)

Written by Barbara Brown

August 27, 2019

Health Canada has released their new guidance document for clinical trial researchers to comply with Part C, Div 5 of the Food & Drug Regulations. Review the document here.

You May Also Like…

Message from N2

Message from N2

The following message is shared together with Karen Arts’s family. With profound sadness, we share the news that Karen...